Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron

Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron

US Patent 6649183 · Granted Nov 18, 2003

Estimated economic value: $26,519,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric sur2020
Antibody fragments against the insulin receptor and uses thereof to treat hypogl2019
Dopamine-agonist combination therapy for improving sleep quality2014
Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combinatio2013
Combination of sedative and a neurotransmitter modulator, and methods for improv2012
Treatment or prophylaxis of migraine or headache disorders using citalopram, esc2010
Methods for treating irritable bowel syndrome using optically pure (-) norcisapr2006
Methods for treating irritable bowel syndrome using optically pure (-) norcisapr2006
Methods for the treatment of neuroleptic and related disorders using ziprasidone2006
Methods for the treatment of neuroleptic and related disorders using ziprasidone2006
Methods of treating and preventing a convulsive state2005
Methods for treating sleep apnea and sleep induced apnea using optically pure (+2004